Exploring environmental and physiological drivers of the annual carbon budget of biocrusts from various climatic zones with a mechanistic data-driven model

Biocrusts are a worldwide phenomenon, contributing substantially to ecosystem functioning. Their growth and survival depend on multiple environmental factors, including climatic ones, and the relations of these factors to physiological processes. Responses of biocrusts to individual environmental factors have been examined in a large number of field and laboratory experiments. These observational data, however, have rarely been assembled into a comprehensive, consistent framework that allows quantitative exploration of the roles of multiple environmental factors and physiological properties for the performance of biocrusts, in particular across climatic regions. Here we used a data-driven mechanistic modelling framework to simulate the carbon balance of biocrusts, a key measure of their growth and survival. We thereby assessed the relative importance of physiological and environmental factors for the carbon balance at six study sites that differ in climatic conditions. Moreover, we examined the role of seasonal acclimation of physiological properties using our framework, since the effects of this process on the carbon balance of biocrusts are poorly constrained so far. We found substantial effects of air temperature, CO2 concentration, and physiological parameters that are related to respiration on biocrust carbon balance, which differ, however, in their patterns across regions. The ambient CO2 concentration is the most important factor for biocrusts from drylands, while air temperature has the strongest impact at alpine and temperate sites. Metabolic respiration cost plays a more important role than optimum temperature for gross photosynthesis at the alpine site; this is not the case, however, in drylands and temperate regions. Moreover, we estimated a small annual carbon gain of 1.5 g m−2 yr−1 by lichen-dominated biocrust and 1.9 g m−2 yr−1 by moss-dominated biocrust at a dryland site, while the biocrusts lost a large amount of carbon at some of the temperate sites (e.g. −92.1 for lichen-dominated and −74.7 g m−2 yr−1 for moss-dominated biocrust). These strongly negative values contradict the observed survival of the organisms at the sites and may be caused by the uncertainty in environmental conditions and physiological parameters, which we assessed in a sensitivity analysis. Another potential explanation for this result may be the lack of acclimation in the modelling approach, since the carbon balance can increase substantially when testing for seasonally varying parameters in the sensitivity analysis. We conclude that the uncertainties in air temperature, CO2 concentration, respiration-related physiological parameters, and the absence of seasonal acclimation in the model for humid temperate and alpine regions may be a relevant source of error and should be taken into account in future approaches that aim at estimating the long-term biocrust carbon balance based on ecophysiological data.</p

Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination

Immunoglobulin (Ig) class switch recombination (CSR) deficiencies are rare primary immunodeficiencies characterized by the lack of switched isotype (IgG/IgA/IgE) production. In some cases, CSR deficiencies can be associated with abnormal somatic hypermutation. Analysis of CSR deficiencies has helped reveal the key functions of CSR-triggering molecules, i.e., CD40L, CD40, and effector molecules such as activation-induced cytidine deaminase and uracil N-glycosylase. We report a new form of B cell–intrinsic CSR deficiency found in three patients with deleterious, homozygous mutations in the gene encoding the PMS2 component of the mismatch repair machinery. CSR was found partially defective in vivo and markedly impaired in vitro. It is characterized by the defective occurrence of double-strand DNA breaks (DSBs) in switch regions and abnormal formation of switch junctions. This observation strongly suggests a role for PMS2 in CSR-induced DSB generation

Effects of climate change and land use intensification on regional biological soil crust cover and composition in southern Africa

Biological soil crusts (biocrusts) form a regular and relevant feature in drylands, as they stabilize the soil, fix nutrients, and influence water cycling. However, biocrust forming organisms have been shown to be dramatically vulnerable to climate and land use change occurring in these regions. In this study, we used Normalized Difference Vegetation Index (NDVI) data of biocrust-dominated pixels (NDVIbiocrust) obtained from hyperspectral and LANDSAT-7 data to analyse biocrust development over time and to forecast future NDVIbiocrust development under different climate change and livestock density scenarios in southern Africa. We validated these results by analysing the occurrence and composition of biocrusts along a mesoclimatic gradient within the study region. Our results show that NDVIbiocrust, which reached maximum values of 0.2 and 0.4 in drier and wetter years, respectively, mainly depended on water availability. A predicted decrease in rainfall events according to all future climate scenarios combined with increased temperatures suggested a pronounced decrease in NDVIbiocrust by the end of the 21st century caused by reduced biocrust coverage. Livestock trampling had similar effects and exacerbated the negative impacts of climate change on biocrust coverage and composition. Data assessed in the field concurred with these results, as reduced biocrust cover and a shift from well-developed to early stages of biocrust development were observed along a gradient of decreasing precipitation and increasing temperatures and livestock density. Our study demonstrates the suitability of multi-temporal series of historical satellite images combined with high-resolution mapping data and Earth system models to identify climate change patterns and their effects on biocrust and vegetation patterns at regional scales.ERC was supported by a Nobel Laureate Paul Crutzen fellowship; the REBIOARID (2018-101921-B-I00) project, funded by the FEDER/Science and Innovation Ministry-National Research Agency through the Spanish National Plan for Research and the European Union Funds for Regional Development; Consejería de Economía, Conocimiento, Empresas y Universidad from the Junta de Andalucía (GlobCRUST project EMERGIA20_0033), the Biodiversity Foundation of the Ministry for the Ecological Transition (BIOCOST project) and the RH2OARID (P18-RT-5130) funded by Consejería de Economía, Conocimiento, Empresas y Universidad from the Junta de Andalucía and the European Union Funds for Regional Development. BW was supported by the Max Planck Society (Nobel Laureate Fellowship) and the German Research Foundation (projects WE2393/2-1 and WE2393/2-2). EG is supported by the European Research Council grant agreement n° 647038 (BIODESERT). The research of US was supported by the German Federal Ministry of Education and Research (BMBF, promotion number 01LG1201N)

Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group

Abstract Infantile myofibromatosis (IM), which is typically diagnosed in young children, comprises a wide clinical spectrum ranging from inconspicuous solitary soft tissue nodules to multiple disseminated tumors resulting in life-threatening complications. Familial IM follows an autosomal dominant mode of inheritance and is linked to PDGFRB germline variants. Somatic PDGFRB variants were also detected in solitary and multifocal IM lesions. PDGFRB variants associated with IM constitutively activate PDGFRB kinase activity in the absence of its ligand. Germline variants have lower activating capabilities than somatic variants and, thus, require a second cis-acting hit for full receptor activation. Typically, these mutant receptors remain sensitive to tyrosine kinase inhibitors such as imatinib. The SIOPE Host Genome Working Group, consisting of pediatric oncologists, clinical geneticists and scientists, met in January 2020 to discuss recommendations for genetic testing and surveillance for patients who are diagnosed with IM or have a family history of IM/PDGFRB germline variants. This report provides a brief review of the clinical manifestations and genetics of IM and summarizes our interdisciplinary recommendations

Large expert-curated database for benchmarking document similarity detection in biomedical literature search

Document recommendation systems for locating relevant literature have mostly relied on methods developed a decade ago. This is largely due to the lack of a large offline gold-standard benchmark of relevant documents that cover a variety of research fields such that newly developed literature search techniques can be compared, improved and translated into practice. To overcome this bottleneck, we have established the RElevant LIterature SearcH consortium consisting of more than 1500 scientists from 84 countries, who have collectively annotated the relevance of over 180 000 PubMed-listed articles with regard to their respective seed (input) article/s. The majority of annotations were contributed by highly experienced, original authors of the seed articles. The collected data cover 76% of all unique PubMed Medical Subject Headings descriptors. No systematic biases were observed across different experience levels, research fields or time spent on annotations. More importantly, annotations of the same document pairs contributed by different scientists were highly concordant. We further show that the three representative baseline methods used to generate recommended articles for evaluation (Okapi Best Matching 25, Term Frequency-Inverse Document Frequency and PubMed Related Articles) had similar overall performances. Additionally, we found that these methods each tend to produce distinct collections of recommended articles, suggesting that a hybrid method may be required to completely capture all relevant articles. The established database server located at https://relishdb.ict.griffith.edu.au is freely available for the downloading of annotation data and the blind testing of new methods. We expect that this benchmark will be useful for stimulating the development of new powerful techniques for title and title/abstract-based search engines for relevant articles in biomedical research.Peer reviewe

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia is an aggressive and frequently lethal myeloproliferative disorder of childhood. Somatic mutations in NRAS, KRAS, or PTPN11 occur in 60% of cases. Monitoring disease status is difficult because of the lack of characteristic leukemic blasts at diagnosis. We designed a fluorescently based, allele-specific polymerase chain reaction assay called TaqMAMA to detect the most common RAS or PTPN11 mutations. We analyzed peripheral blood and/or bone marrow of 25 patients for levels of mutant alleles over time. Analysis of pre–hematopoietic stem-cell transplantation, samples revealed a broad distribution of the quantity of the mutant alleles. After hematopoietic stem-cell transplantation, the level of the mutant allele rose rapidly in patients who relapsed and correlated well with falling donor chimerism. Simultaneously analyzed peripheral blood and bone marrow samples demonstrate that blood can be monitored for residual disease. Importantly, these assays provide a sensitive strategy to evaluate molecular responses to new therapeutic strategies

Genetic testing and surveillance in infantile myofibromatosis : a report from the SIOPE Host Genome Working Group

Infantile myofibromatosis (IM), which is typically diagnosed in young children, comprises a wide clinical spectrum ranging from inconspicuous solitary soft tissue nodules to multiple disseminated tumors resulting in life-threatening complications. Familial IM follows an autosomal dominant mode of inheritance and is linked toPDGFRBgermline variants. SomaticPDGFRBvariants were also detected in solitary and multifocal IM lesions.PDGFRBvariants associated with IM constitutively activate PDGFRB kinase activity in the absence of its ligand. Germline variants have lower activating capabilities than somatic variants and, thus, require a second cis-acting hit for full receptor activation. Typically, these mutant receptors remain sensitive to tyrosine kinase inhibitors such as imatinib. The SIOPE Host Genome Working Group, consisting of pediatric oncologists, clinical geneticists and scientists, met in January 2020 to discuss recommendations for genetic testing and surveillance for patients who are diagnosed with IM or have a family history of IM/PDGFRBgermline variants. This report provides a brief review of the clinical manifestations and genetics of IM and summarizes our interdisciplinary recommendations

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia is an aggressive and frequently lethal myeloproliferative disorder of childhood. Somatic mutations in NRAS, KRAS, or PTPN11 occur in 60% of cases. Monitoring disease status is difficult because of the lack of characteristic leukemic blasts at diagnosis. We designed a fluorescently based, allele-specific polymerase chain reaction assay called TaqMAMA to detect the most common RAS or PTPN11 mutations. We analyzed peripheral blood and/or bone marrow of 25 patients for levels of mutant alleles over time. Analysis of pre–hematopoietic stem-cell transplantation, samples revealed a broad distribution of the quantity of the mutant alleles. After hematopoietic stem-cell transplantation, the level of the mutant allele rose rapidly in patients who relapsed and correlated well with falling donor chimerism. Simultaneously analyzed peripheral blood and bone marrow samples demonstrate that blood can be monitored for residual disease. Importantly, these assays provide a sensitive strategy to evaluate molecular responses to new therapeutic strategies